Literature DB >> 10777662

Physical interactions among human checkpoint control proteins HUS1p, RAD1p, and RAD9p, and implications for the regulation of cell cycle progression.

H Hang1, H B Lieberman.   

Abstract

Schizosaccharomyces pombe hus1 promotes radioresistance and hydroxyurea resistance, as well as S and G2 phase checkpoint control. We isolated a human cDNA homologous to hus1, called HUS1. The major focus of this report is on a detailed analysis of the physical interactions of the HUS1-encoded protein and two other checkpoint control proteins, RAD1p and RAD9p, implicated in the cellular response to DNA damage. We found that HUS1p interacts with itself and the N-terminal region of RAD1p. In contrast, the C-terminal portion of the checkpoint protein RAD9p is essential for interacting with HUS1p and the C-terminal region of RAD1p. Since the N-terminal portion of RAD9p was previously demonstrated to participate in apoptosis, this protein likely has at least two functional domains, one that regulates programmed cell death and another that regulates cell cycle checkpoint control. Truncated versions of HUS1p are unable to bind RAD1p, RAD9p, or another HUS1p molecule. RAD1p-RAD1p and RAD9p-RAD9p interactions can be demonstrated by coimmunoprecipitation, but not by two-hybrid analysis, suggesting that the proteins associate as part of a complex but do not interact directly. Northern blot analysis indicates that HUS1 is expressed in different tissues, but the mRNA is most predominant in testis where high levels of RAD1 and RAD9 message have been detected. These studies suggest that HUS1p, RAD9p, and RAD1p form a complex in human cells and may function in a meiotic checkpoint in addition to the cell cycle delays induced by incomplete DNA replication or DNA damage. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777662     DOI: 10.1006/geno.2000.6142

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  22 in total

1.  Purification and characterization of human DNA damage checkpoint Rad complexes.

Authors:  L A Lindsey-Boltz; V P Bermudez; J Hurwitz; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Preferential binding of ATR protein to UV-damaged DNA.

Authors:  Keziban Unsal-Kaçmaz; Alexander M Makhov; Jack D Griffith; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

3.  Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses.

Authors:  Chunbo Zhang; Yuheng Liu; Zhishang Hu; Lili An; Yikun He; Haiying Hang
Journal:  Protein Cell       Date:  2011-06-02       Impact factor: 14.870

Review 4.  The role of RAD9 in tumorigenesis.

Authors:  Howard B Lieberman; Joshua D Bernstock; Constantinos G Broustas; Kevin M Hopkins; Corinne Leloup; Aiping Zhu
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

5.  Molecular modeling-based analysis of interactions in the RFC-dependent clamp-loading process.

Authors:  Ceslovas Venclovas; Michael E Colvin; Michael P Thelen
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

Review 6.  p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.

Authors:  Howard B Lieberman; Sunil K Panigrahi; Kevin M Hopkins; Li Wang; Constantinos G Broustas
Journal:  Radiat Res       Date:  2017-01-31       Impact factor: 2.841

7.  Physical and functional interactions between MutY glycosylase homologue (MYH) and checkpoint proteins Rad9-Rad1-Hus1.

Authors:  Guoli Shi; Dau-Yin Chang; Chih-Chien Cheng; Xin Guan; Ceslovas Venclovas; A-Lien Lu
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

8.  Mutant alleles of Schizosaccharomyces pombe rad9(+) alter hydroxyurea resistance, radioresistance and checkpoint control.

Authors:  H Hang; S J Rauth; K M Hopkins; H B Lieberman
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

9.  Interaction of apurinic/apyrimidinic endonuclease 2 (Apn2) with Myh1 DNA glycosylase in fission yeast.

Authors:  Jin Jin; Bor-Jang Hwang; Po-Wen Chang; Eric A Toth; A-Lien Lu
Journal:  DNA Repair (Amst)       Date:  2014-02-01

10.  Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management.

Authors:  Howard B Lieberman; Alex J Rai; Richard A Friedman; Kevin M Hopkins; Constantinos G Broustas
Journal:  Transl Cancer Res       Date:  2018-01-14       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.